SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Wednesday reported a loss of $11.7 million in its first quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 24 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The molecular diagnostic company posted revenue of $31.1 million in the period.
Veracyte shares have fallen almost 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $27.18, an increase of roughly 7% in the last 12 months.